Directory › Lonza

Lonza — Visp

Visp, Switzerland · CDMO

This is a record of what regulators published, not a rating.

Site facts

Company
Lonza
Name(s) in FDA data
Lonza AG
FEI number(s)
3002930340 (present in FDA Data Dashboard records for this name and city)
Location (as in FDA data)
Visp, Switzerland
Records matched
8 FDA inspections
Most recent FDA inspection in dataset
28 Mar 2023 — VAI

Capabilities (from the company's website)

  • Biologics drug substance
    …acture of products for pharmaceutical applications. Products manufactured in Visp include mammalian and microbial biopharmaceuticals, small molecules, highly potent APIs, peptides and bioco…
  • Small molecule
    …ations. Products manufactured in Visp include mammalian and microbial biopharmaceuticals, small molecules, highly potent APIs, peptides and bioconjugates including antibody-drug conjugates (ADCs)…
  • API / drug substance (chemical)
    …n Visp include mammalian and microbial biopharmaceuticals, small molecules, highly potent APIs, peptides and bioconjugates including antibody-drug conjugates (ADCs). It is also home to…
  • Highly potent (HPAPI)
    …manufactured in Visp include mammalian and microbial biopharmaceuticals, small molecules, highly potent APIs, peptides and bioconjugates including antibody-drug conjugates (ADCs). It is also ho…
  • Peptides & oligonucleotides
    …include mammalian and microbial biopharmaceuticals, small molecules, highly potent APIs, peptides and bioconjugates including antibody-drug conjugates (ADCs). It is also home to our pione…
  • ADCs & bioconjugates
    …alian and microbial biopharmaceuticals, small molecules, highly potent APIs, peptides and bioconjugates including antibody-drug conjugates (ADCs). It is also home to our pioneering Ibex® Solu…
  • Cell & gene therapy
    …dels provide customized solutions for the production of mammalian and microbial vaccines, cell and gene therapies. Ibex Design offers fixed-price product packaging and fast delivery options for…
  • Clinical trial supply & packaging
    …n and microbial vaccines, cell and gene therapies. Ibex Design offers fixed-price product packaging and fast delivery options for preclinical and Phase I stages of drug development, as well…
  • Analytical testing
    …rom small biotechs to large pharma. Our wide-ranging capabilities include API process and analytical method development, kilo-lab manufacturing, process transfer, and clinical-scale manufacturing.…

Taken from the company's web page for this site. Source: https://www.lonza.com/about-us/our-locations/visp-switzerland, checked 16 Oct 2026. Quoted text shows the wording each tag is based on.

Regulatory timeline

Newest first. Each entry links to the published source. Inspection classifications: NAI = no action indicated, VAI = voluntary action indicated, OAI = official action indicated (FDA definitions). Posted 483 citations are FDA's short summaries, not the full Form 483.

  1. 28 Mar 2023
    FDA inspection FDA inspection classified VAI

    Voluntary Action Indicated (VAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3002930340, inspection ID 1204183)

  2. 15 Dec 2017
    FDA inspection FDA inspection classified VAI

    Voluntary Action Indicated (VAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3002930340, inspection ID 1035618)

  3. 11 Mar 2016
    FDA inspection FDA inspection classified VAI

    Voluntary Action Indicated (VAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3002930340, inspection ID 967811)

  4. 29 Aug 2014
    FDA inspection FDA inspection classified VAI

    Voluntary Action Indicated (VAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3002930340, inspection ID 893677)

  5. 02 Apr 2014
    FDA inspection FDA inspection classified NAI

    No Action Indicated (NAI). Product type(s): Food/Cosmetics. Project area(s): Food Composition, Standards, Labeling and Econ; Foodborne Biological Hazards.

    Source: FDA Data Dashboard – Inspections (FEI 3002930340, inspection ID 877791)

  6. 12 Apr 2013
    FDA inspection FDA inspection classified NAI

    No Action Indicated (NAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3002930340, inspection ID 826508)

  7. 18 Sep 2012
    FDA inspection FDA inspection classified NAI

    No Action Indicated (NAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3002930340, inspection ID 818560)

  8. 24 Jun 2010
    FDA inspection FDA inspection classified VAI

    Voluntary Action Indicated (VAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 3002930340, inspection ID 671625)

This is a record of what regulators published, not a rating. Absence of a record here does not mean no record exists; see methodology for what we check and how records are matched.